Stockscreener 앱 받기
0.825
8.77%
0.0665
전일 마감가:
$0.7585
열려 있는:
$0.79
하루 거래량:
100.69K
Relative Volume:
0.82
시가총액:
$13.94M
수익:
-
순이익/손실:
$-14.58M
주가수익비율:
-0.7301
EPS:
-1.13
순현금흐름:
$-9.80M
1주 성능:
-3.52%
1개월 성능:
-40.65%
6개월 성능:
-63.00%
1년 성능:
-76.43%
1일 변동 폭
$0.7601
$0.835
1주일 범위
$0.72
$0.9061
52주 변동 폭
$0.72
$5.28
Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile
명칭
Acurx Pharmaceuticals Inc
전화
917-533-1469
주소
259 LIBERTY AVENUE, STATEN ISLAND
ACXP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACXP
Acurx Pharmaceuticals Inc
|
0.825 | 13.94M | 0 | -14.58M | -9.80M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Acurx Pharmaceuticals Inc 주식(ACXP)의 최신 뉴스
ACXP stock touches 52-week low at $0.72 amid market challenges - Investing.com Canada
Acurx Pharmaceuticals to Present Latest Antibiotic Developments at 2025 Microcap Conference - StockTitan
Acurx Pharmaceuticals to Present at the Microcap Conference, January 28, 2025January 30, 2025 - Eagle-Tribune
Acurx Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 13, 2024 - Kilgore News Herald
Acurx prepares for Phase 3 trials in C. difficile treatment By Investing.com - Investing.com Canada
Acurx prepares for Phase 3 trials in C. difficile treatment - Investing.com India
Acurx's Breakthrough CDI Antibiotic Advances Toward Global Phase 3 Trial Following FDA Green Light - StockTitan
ACXP stock touches 52-week low at $0.79 amid market challenges - Investing.com UK
Here's Why Acurx Pharmaceuticals (ACXP) Is a Great 'Buy the Bottom' Stock Now - MSN
ACXP stock touches 52-week low at $1.01 amid market challenges - Investing.com Canada
MicroStrategy Now Has Copycats Buying Bitcoin as Prices Near $100,000 - Barron's
Nasdaq-Listed Acurx Invests $1M in Bitcoin—What’s Behind the Move? - Watcher Guru
Acurx Pharmaceuticals Allocates $1 Million to Bitcoin as Reserve Asset, Shares Slide 26% - Binance
Acurx Pharmaceuticals Shares Slide 17% After Disclosing Bitcoin Investment - MarketWatch
ACXP stock touches 52-week low at $1.5 amid market challenges - Investing.com UK
Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset - Il Giornale d'Italia
Acurx Pharmaceuticals adopts Bitcoin as a reserve asset - TU News
Acurx Board of Directors Approves Bitcoin as Treasury Reserve Asset | DigitalMore.co - Digital More
Acurx Pharmaceuticals allocates $1M for Bitcoin reserve - Investing.com
Acurx Pharmaceuticals allocates $1M for Bitcoin reserve By Investing.com - Investing.com UK
ACXPAcurx Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan
Acurx Pharma Advances CDI Drug to Phase 3 Trials After Promising Clinical Data | ACXP Stock News - StockTitan
HC Wainwright Has Bullish Estimate for ACXP FY2024 Earnings - Defense World
Acurx Pharmaceuticals Reports Q3 2024 Financial Results and Business Update - Defense World
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Sees Large Decline in Short Interest - Defense World
Acurx Pharmaceuticals’ (ACXP) Buy Rating Reiterated at HC Wainwright - Defense World
Keith Meister's Corvex opens fresh stakes in Dollar Tree, APD, exits CAE: top Q3 trades - MSN
Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Q3 Loss - MSN
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q3 2024 Earnings Call Transcript - Insider Monkey
Acurx Pharmaceuticals Reports Promising Q3 2024 Results - TipRanks
Acurx Pharma Q3: New Patent Win & Trial Progress Despite Cash Decline to $5.8M | ACXP Stock News - StockTitan
Acurx Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Acurx Pharmaceuticals (ACXP) Set to Announce Quarterly Earnings on Wednesday - Defense World
New to The Street to Air as Sponsored Programming on Bloomberg Friday, November 1st, Featuring Modular Medical, OriginClear With Shark Tank's Kevin Harrington, Acurx Pharmaceuticals, the Sustainable Green Team, and SEKUR's "Hack of the Week - Big News Network
New to The Street to Air as Sponsored Programming on Bloomberg Friday, November 1st, Featuring Modular Medical, OriginClear With Shark Tank's Kevin Harrington, Acurx Pharmaceuticals, the... - Markets Insider
New to The Street to Air as Sponsored Programming on Bloomberg Friday, November 1st, Featuring Modular Medical, OriginClear With Shark Tank's Kevin Harrington, Acurx Pharmaceuticals, the Sustainable Green Team, and SEKUR’s "Hack of the Week" - AccessWire
New to The Street on Fox Business Premieres Exclusive Sponsored Programming Tonight Featuring Modular Medical (NASDAQ:MODD), Acurx Pharmaceuticals (NASDAQ:ACXP), and LightPath Technologies (NASDAQ:LPTH) - Quantisnow
AccreditedEvents.com Unveils Premier Lineup for November and December Investor Events - Big News Network
Acurx reports positive Phase 2 results for CDI treatment ibezapolstat - Investing.com India
Acurx reports positive Phase 2 results for CDI treatment ibezapolstat By Investing.com - Investing.com South Africa
Acurx Ready To Expand Pipeline With Anthrax Treatment (NASDAQ:ACXP) - Seeking Alpha
Acurx Announces New Bile Acid and Microbiome Analyses from Ph2b Trial of Ibezapolstat in CDI Patients Presented at IDWeek Scientific Conference - StockTitan
Acurx Pharmaceuticals Announces Participation at The Spartan Capital Investor Conference to Showcase Growth Companies and Foster High-Level Investor Engagement - StockTitan
Acurx Pharmaceuticals Inc (ACXP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Acurx Pharmaceuticals Inc 주식 (ACXP) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| DELUCCIA ROBERT J | Director |
Jan 03 '24 |
Option Exercise |
3.55 |
19,737 |
70,066 |
960,935 |
| LUCI DAVID P | President and CEO |
Jan 03 '24 |
Option Exercise |
3.55 |
19,737 |
70,066 |
1,048,197 |
2.88%
2.65%
자본화:
|
볼륨(24시간):